Health Promotion and disease prevention

at
Categories
Tags

 

Presentation: Critical Review & Evaluation of Health Promotion Protocol/Practice

complete a review of a screening tool utilized by nurse practitioners in maintaining individual, family, or community health.
Your presentation should:
1. Identify and select a screening tool
2. Research of ethical, economical and legal issues relative to the practice in relation to health promotion protocol/practice.
3. Provide recommendations.

• Presentation is original work and logically organized in the current APA style including citation of references.
• Incorporate a minimum of 4 current (published within the last five years) scholarly journal articles or primary legal sources (statutes, court opinions) within your work.
• PowerPoint presentation with 10-15 slides, excluding the title slide and the reference slide.
• The presentation is clear and concise and students will lose points for improper grammar, punctuation and misspelling.
• Speaker notes expanded upon and clarified content on the slides.

Sample Solution

Screening Tool: Depression, Anxiety, and Stress Scale (DASS-21)

Ethical, Economic, and Legal Issues

Ethical Issues:

  • Informed Consent: Ensure patients understand the purpose, risks, and benefits of the screening tool before participation.
  • Confidentiality: Maintain patient confidentiality and protect sensitive health information.
  • Cultural Sensitivity: Adapt the screening tool to address cultural variations and ensure it is culturally appropriate.

Economic Issues:

  • Cost-effectiveness: Evaluate the cost-effectiveness of the DASS-21 in terms of identifying individuals at risk for mental health disorders and guiding appropriate interventions.
  • Resource Allocation: Consider the allocation of resources for implementing and interpreting the screening tool, including training for healthcare providers and access to mental health services.

Legal Issues:

  • HIPAA Compliance: Ensure that the screening tool and its implementation comply with the Health Insurance Portability and Accountability Act (HIPAA) regulations regarding patient privacy and data security.
  • Informed Consent: Obtain informed consent from patients before administering the screening tool, as required by law.

Recommendations

  • Wide-scale Implementation: The DASS-21 is a valuable tool for screening individuals for depression, anxiety, and stress. It should be widely implemented in healthcare settings to identify individuals at risk and facilitate early intervention.
  • Cultural Adaptation: The DASS-21 may need to be adapted to address cultural variations and ensure its relevance to different populations.
  • Integration into Electronic Health Records: Integrating the DASS-21 into electronic health records can streamline the screening process and improve data collection and analysis.
  • Staff Training: Healthcare providers should receive training on the administration, interpretation, and follow-up of the DASS-21.
  • Access to Mental Health Services: Ensure that individuals who screen positive for mental health disorders have access to appropriate mental health services and support.

References

  1. Lovibond, P. H., & Lovibond, S. H. (1995). The Depression Anxiety Stress Scales-21: A brief self-report measure. Behavior Research and Therapy, 33(1), 33-44.
  2. American Psychiatric Association. (2022). Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition (DSM-5). American Psychiatric Association.
  3. National Institute of Mental Health. (2023). Depression. National Institutes of Health. https://www.nimh.nih.gov/health/topics/depression

This question has been answered.

Get Answer